Hugh Rosen

Hugh Rosen

Director/Board Member presso REGULUS THERAPEUTICS INC.

Patrimonio netto: 5 100 $ in data 31/03/2024

64 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Hugh Rosen is the founder of Receptos LLC, which was founded in 2008.
He is currently the Chairman & President of ActivX Biosciences, Inc. since 2017 and an Independent Director of Regulus Therapeutics, Inc. since 2016.
Dr. Rosen was a Director of the Association of American Physicians and an Executive Director-Immunology & Rheumatology at Merck Research Laboratories Massachusetts LLC.
He was also a Scientific Director at Scleroderma Foundation from 1992 to 2000 and a Professor at The Scripps Research Institute from 2002 to 2017.
Dr. Rosen holds a doctorate degree from the University of Oxford and the University of Cape Town.
Dr. Rosen is also the founder of BlackThorn Therapeutics, Inc.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
10/08/2023 1 771 ( 0.00% ) 5 100 $ 31/03/2024

Posizioni attive di Hugh Rosen

SocietàPosizioneInizio
REGULUS THERAPEUTICS INC. Director/Board Member 02/06/2016
Chairman 01/04/2017
Tutte le posizioni attive di Hugh Rosen

Precedenti posizioni note di Hugh Rosen

SocietàPosizioneFine
Corporate Officer/Principal 01/03/2017
Scleroderma Foundation Chief Tech/Sci/R&D Officer 01/01/2000
Founder -
Director/Board Member -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Hugh Rosen

Formazione di Hugh Rosen

University of Oxford Doctorate Degree
University of Cape Town Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hugh Rosen

Relazioni

60

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
REGULUS THERAPEUTICS INC.

Health Technology

Aziende private6

Health Technology

Health Technology

Health Technology

Scleroderma Foundation

Health Technology

Commercial Services

Vedi le connessioni aziendali